InMed Pharmaceuticals (OTCMKTS:IMLFF) Shares Down 7.3%

Shares of InMed Pharmaceuticals Inc. (OTCMKTS:IMLFFGet Free Report) dropped 7.3% during trading on Friday . The stock traded as low as $0.22 and last traded at $0.24. Approximately 621,030 shares traded hands during trading, an increase of 5,362% from the average daily volume of 11,369 shares. The stock had previously closed at $0.25.

InMed Pharmaceuticals Stock Performance

The company’s 50-day moving average price is $0.30 and its 200 day moving average price is $0.35.

About InMed Pharmaceuticals

(Get Free Report)

InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain.

Further Reading

Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.